4Holmes J, Stanko J, Varchenko M, et al. Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model [ J ].Toxicol Sci, 1998,46(2): 342 - 351.
5Troy L, McFarland K, Littman-Power S, et al. Cisplatin-based therapy: a neurological and neuropsychological review [ J].Psychooncology, 2000,9( 1 ): 29 - 39.
6Hamers FPT, van der Hoop RG, Steerenburg PA, et al. Putative neurotrophic factors in the protection of cisplatin-induced peripheral neuropathy in rats[J]. Toxicol Appl Pharmacol, 1991,111(3) :514 -522.
7McKeage MJ,Hsu T, Screnci D, et al. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs [ J ]. Br J Cancer ,2001,85(8): 1219 - 1225.
8Jordan P, Carmo-fonseca M. Cisplatin inhibits synthesis of ribosomal RNA in vivo [ J]. Nucl Acids Res, 1998,26(12) :2831 - 2836.
9Screnci D, Mckeage MJ, Galettis P, et al. Relationships between hydrophobicity,reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs[J]. Br J Cancer,2000,82(4) :966 -972.
10Pace A, Savarese A, Picardo M, et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy [ J ]. J Clin Oncol , 2003,21 (5): 927 - 931.
